Specialty Networks and Patient Support Services Summit
August 29 to August 30, 2023
Philadephia, Pennsylvania, United States
Join peers involved in specialty distribution, patient support services, network design, and compliance to break down silos and strategize efforts to improve patient support and access from manufacturer to patient, provider, and other channel partners. Hear directly from specialty pharmacies, payers, PBMs, government agencies, health systems, and industry leaders to ensure specialty product success and enhance patient care. This Summit includes tailored content on specialty network design and patient support to customize the learning experience as well as shared content to maximize collaboration and knowledge-sharing.
The 2nd Oligonucleotides CMC and Analytical Development Summit return this August to Boston. With the unprecedented growth of the oligonucleotides market, reaching $2b by 2027 and with over 250 in the clinical phase of drug development, we now seek to unlock the potential of oligonucleotides beyond rare disease to treat large patient populations for undruggable targets. In the last 12 months alone, there have been a number of advances in the field with Switch Therapeutics advancing their first RNAi technology, Avidity turbocharging their antibody-oligo conjugate and Ansa Biotech successfully synthesizing the world's longest oligonucleotide! Despite this, drug developers still face challenges in manufacturability and lack of concrete regulatory protocols.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our